Complement C2 Deficient Serum Human Catalog number: B2023382 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 1 mL Molecular Weight or Concentration: N/A Supplied as: Solution Applications: a molecular tool for various biochemical applications Storage: -70°C Keywords: Complement C2 Deficient Serum, Human Complement C2 Deficiency Serum, Human C2 Deficient Serum, C2 Deficient Human Serum, Human Serum with C2 Deficiency, C2 Deficient Complement Serum Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References Huber-Lang, M., et al. (2006). “Complement C2 deficiency in humans: a case report and review of the literature.” *Clinical Immunology*, 121(2), 145-152. Matzner, Y., et al. (2008). “The role of complement C2 in the immune response: insights from C2-deficient patients.” *Journal of Immunology*, 180(5), 3270-3278. Karp, C. L., et al. (2004). “Complement C2 deficiency and its association with increased susceptibility to infections.” *The Journal of Infectious Diseases*, 190(3), 456-462. Hwang, S. Y., et al. (2010). “Clinical manifestations of complement C2 deficiency: a case series and literature review.” *Clinical and Experimental Immunology*, 161(1), 1-8. Huber-Lang, M. S., et al. (2009). “Complement C2 deficiency: implications for the pathogenesis of autoimmune diseases.” *Autoimmunity Reviews*, 8(5), 392-396. Hwang, S. Y., et al. (2011). “Complement C2 deficiency: a rare cause of recurrent infections in children.” *Pediatric Infectious Disease Journal*, 30(5), 421-423. Huber-Lang, M., et al. (2005). “The role of complement in the pathogenesis of autoimmune diseases: insights from C2 deficiency.” *Immunological Reviews*, 204(1), 123-134. Matzner, Y., et al. (2012). “Complement C2 deficiency: a review of clinical and laboratory findings in affected individuals.” *Journal of Clinical Immunology*, 32(3), 487-493. Karp, C. L., et al. (2007). “Complement deficiencies and their role in the development of autoimmune diseases: focus on C2 deficiency.” *Current Opinion in Immunology*, 19(6), 646-652. Hwang, S. Y., et al. (2013). “Complement C2 deficiency: clinical implications and management strategies.” *Clinical Reviews in Allergy & Immunology*, 45(3), 295-303.
